Researchers are excited about this new drug, a novel dual agonist showing significant outcomes in initial trials for body reduction . It functions by modulating two pathways : GLP-1 and GIP, which , when https://katrinazrto095233.shotblogs.com/the-new-hope-for-size-loss-54882092